Skip to content

Drug interactions

Epcoritamab + Ethosuximide

Severity: Moderate

Epcoritamab and Ethosuximide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epcoritamab induces cytokine release that may temporarily suppress CYP activity. Ethosuximide levels may rise, particularly after the first doses.

What this interaction means in plain words

Epcoritamab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Epcoritamab belongs to Oncology; Ethosuximide belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP3A4 activity.

What to do

Monitor for ethosuximide toxicity during the initial dosing period and any cytokine release syndrome. Check serum levels if symptoms occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Epcoritamab and Ethosuximide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Epcoritamab with Ethosuximide?

MediHelp rates the interaction as moderate. Epcoritamab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Epcoritamab induces cytokine release that may temporarily suppress CYP activity. Ethosuximide levels may rise, particularly after the first doses.

How serious is the interaction between Epcoritamab and Ethosuximide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide toxicity during the initial dosing period and any cytokine release syndrome. Check serum levels if symptoms occur.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in